Opioid-associated iatrogenic withdrawal in critically ill adult patients: a multicenter prospective observational study

Pan Pan Wang, Elaine Huang, Xue Feng, Charles-André Bray, Marc M Perreault, Philippe Rico, Patrick Bellemare, Paul Murgoi, Céline Gélinas, Annie Lecavalier, Dev Jayaraman, Anne Julie Frenette, David Williamson, Pan Pan Wang, Elaine Huang, Xue Feng, Charles-André Bray, Marc M Perreault, Philippe Rico, Patrick Bellemare, Paul Murgoi, Céline Gélinas, Annie Lecavalier, Dev Jayaraman, Anne Julie Frenette, David Williamson

Abstract

Background: Opioids and benzodiazepines are frequently used in the intensive care unit (ICU). Regular use and prolonged exposure to opioids in ICU patients followed by abrupt tapering or cessation may lead to iatrogenic withdrawal syndrome (IWS). IWS is well described in pediatrics, but no prospective study has evaluated this syndrome in adult ICU patients. The objective of this study was to determine the incidence of IWS caused by opioids in a critically ill adult population. This multicenter prospective cohort study was conducted at two level-1 trauma ICUs between February 2015 and September 2015 and included 54 critically ill patients. Participants were eligible if they were 18 years and older, mechanically ventilated and had received more than 72 h of regular intermittent or continuous intravenous infusion of opioids. For each enrolled patient and per each opioid weaning episode, presence of IWS was assessed by a qualified ICU physician or senior resident according to the 5th edition of Diagnostic and Statistical Manual of Mental Disorders criteria for opioid withdrawal.

Results: The population consisted mostly of males (74.1%) with a median age of 50 years (25th-75th percentile 38.2-64.5). The median ICU admission APACHE II score was 22 (25th-75th percentile 12.0-28.2). The overall incidence of IWS was 16.7% (95% CI 6-27). The median cumulative opioid dose prior to weaning was higher in patients with IWS (245.7 vs. 169.4 mcg/kg, fentanyl equivalent). Patients with IWS were also exposed to opioids for a longer period of time as compared to patients without IWS (median 151 vs. 125 h). However, these results were not statistically significant.

Conclusions: IWS was occasionally observed in this very specific population of mechanically ventilated, critically ill ICU patients. Further studies are needed to confirm these preliminary results and identify risk factors.

Keywords: Adult; Critically ill; DSM-V; Iatrogenic withdrawal syndrome; Intensive care unit; Mechanical ventilation; Opioids.

Figures

Fig. 1
Fig. 1
Study flowchart

References

    1. Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263–306. doi: 10.1097/CCM.0b013e3182783b72.
    1. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119–141. doi: 10.1097/00003246-200201000-00020.
    1. Devlin JW, Mallow-Corbett S, Riker RR. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med. 2010;38:S231–S243. doi: 10.1097/CCM.0b013e3181de125a.
    1. Fernandez-Carrion F, Gaboli M, Gonzalez-Celador R, Gomez de Quero-Masia P, Fernandez-de Miguel S, et al. Withdrawal syndrome in the pediatric intensive care unit. Incidence and risk factors. Med Intensiva/Sociedad Espanola de Medicina Intensiva y Unidades Coronarias. 2013;37:67–74. doi: 10.1016/j.medin.2012.02.009.
    1. Franck LS, Naughton I, Winter I. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs. 2004;20:344–351. doi: 10.1016/j.iccn.2004.07.008.
    1. Hughes J, Gill A, Leach HJ, Nunn AJ, Billingham I, et al. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr. 1994;83:1194–1199. doi: 10.1111/j.1651-2227.1994.tb18280.x.
    1. Birchley G. Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: a review of recent literature. Nurs Crit Care. 2009;14:26–37. doi: 10.1111/j.1478-5153.2008.00311.x.
    1. Katz R, Kelly HW, Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med. 1994;22:763–767. doi: 10.1097/00003246-199405000-00009.
    1. Finnegan LP, Connaughton JF, Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2:141–158.
    1. Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000;28:2122–2132. doi: 10.1097/00003246-200006000-00079.
    1. Biswas AK, Feldman BL, Davis DH, Zintz EA. Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal. Clin Toxicol. 2005;43:207–209. doi: 10.1081/CLT-53099.
    1. Franck LS, Vilardi J, Durand D, Powers R. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Criti Care. 1998;7:364–369.
    1. Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998;26:676–684. doi: 10.1097/00003246-199804000-00015.
    1. American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Publishing. xliv, 947 pages pp.
    1. Ista E, van Dijk M, Gamel C, Tibboel D, de Hoog M. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation. Crit Care Med. 2008;36:2427–2432. doi: 10.1097/CCM.0b013e318181600d.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅